TapewireFind a company

person · Reporting owner

LOY BERTRAND

Disclosed activity across 4 companies

Tapewire entity
26939
SEC CIK
0001197452

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ASHLAND INC.ASH · Entity 4139DirectorMay 15, 2026May 18, 2026
HARVARD BIOSCIENCE INCHBIO · Entity 7369DirectorMay 21, 2024May 23, 2024
ITT INC.ITT · Entity 8806DirectorAugust 01, 2026August 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ASHLAND INC.

Report date May 15, 2026 · Filed May 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,741 Reported balance After 2026-05-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-05-15 · Grant · Acquired 1,741 · Balance 1,741

F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2: Grant of Restricted Stock Units granted under Ashland's Omnibus Incentive Plan. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit (RSU) represents a right to receive one (1) share of Ashland Common Stock.

F2: Grant of Restricted Stock Units granted under Ashland's Omnibus Incentive Plan. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

HARVARD BIOSCIENCE INC

Report date May 21, 2024 · Filed May 23, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect56,575 Reported balance After 2024-05-21 transaction · row 1
1 source row

Row 1 · 2024-05-21 · Grant · Acquired 56,575 · Balance 56,575

F1: Represents an award of 56,575 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.

Common StockSEC Table I · non-derivativeIndirectby Bertrand M. Loy Revocable Trust499,633 Reported balance Holding disclosure · report date 2024-05-21 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 499,633

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of 56,575 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.

ITT INC.

Report date August 01, 2026 · Filed August 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect756 Reported balance After 2026-08-01 transaction · row 1
1 source row

Row 1 · 2026-08-01 · Grant · Acquired 756 · Balance 756

F1: Reflects an award of restricted stock units, all of which are scheduled to vest on the business day immediately prior to the ITT 2027 Annual Meeting of Shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects an award of restricted stock units, all of which are scheduled to vest on the business day immediately prior to the ITT 2027 Annual Meeting of Shareholders.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ENTEGRIS INC

Report date August 04, 2026 · Filed August 04, 2026

Section 16 reporting ended · disclosed 2026-08-04. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 20, 2024 Filed Feb 21, 2024 22:00 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 20,534 $0.00 $0.00
Disclosure

SEC source: 0001197452-24-000002 · wk-form4_1708552838.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,967

F2 · shares: Awarded in connection with the settlement of performance share units for the 2021-2023 performance cycle.

F3 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 22:00 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 15,756 $136.81 $2,155,578.36
Disclosure

SEC source: 0001197452-24-000002 · wk-form4_1708552838.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,433

F1 · shares: Shares automatically withheld upon settlement of restricted stock units to satisfy tax withholding obligations.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:27 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 9,357 $95.87 $897,055.59
Disclosure

SEC source: 0001197452-23-000008 · wk-form4_1692304020.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,189

Read SEC document
May 22, 2023 Filed May 23, 2023 20:03 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 GrantCommon Stock 31,516 $0.00 $0.00
Disclosure

SEC source: 0000921895-23-001327 · form412799loy_05232023.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,009

F1 · shares: Represents an award of 31,516 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 15, 2023, immediately prior to the commencement of such meeting, and (ii) May 22, 2024.

F2 · balance_after: Includes (a) the award described in footnote (1) above and (b) 47,493 shares of common stock held by the Reporting Person.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 21:02 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 14,126 $85.48 $1,207,490.48
Disclosure

SEC source: 0001197452-23-000006 · wf-form4_167701329970403.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,546

F1 · shares: Shares automatically withheld upon settlement of restricted stock units to satisfy tax withholding obligations.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:05 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 8,727 $84.94 $741,271.38
Disclosure

SEC source: 0001197452-23-000004 · wf-form4_167649509702976.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,672

F3 · shares: Shares automatically withheld upon settlement of performance share units to satisfy tax withholding obligations.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 21:05 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 19,676 $0.00 $0.00
Disclosure

SEC source: 0001197452-23-000004 · wf-form4_167649509702976.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,399

F1 · shares: Awarded in connection with the settlement of performance share units for the 2020-2022 performance cycle.

F2 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:08 UTC ENTEGRIS INC ENTG · Entity 3271 GrantEmployee Stock Option (Right to Buy) · Derivative 91,704 $0.00 Strike: $80.71 $0.00
Disclosure

SEC source: 0001197452-23-000002 · wf-form4_167537206657747.xml · derivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,704

Underlying: Common Stock · 91,704 shares

Expires 2030-02-19

F2 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2024 and thereafter on February 19, 2025, February 19, 2026 and February 19, 2027.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 21:08 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 51,292 $0.00 $0.00
Disclosure

SEC source: 0001197452-23-000002 · wf-form4_167537206657747.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,723

F1 · shares: These shares are restricted stock units with restrictions that lapse over a four-year period with respect to 25% of these shares per year beginning February 19, 2024 and thereafter on February 19, 2025, February 19, 2026 and February 19, 2027.

F2 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

Read SEC document
September 06, 2022 Filed Sep 15, 2022 20:02 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 OtherCommon Stock 108,715 $0.00 $0.00
Disclosure

SEC source: 0000921895-22-002653 · form412799001_09152022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by The BZH Trust

Disclosed balance after: 0

F1 · kind: On September 6, 2022, the Reporting Person transferred 108,715 shares of common stock to the Bertrand M. Loy Revocable Trust.

F2 · shares: In addition to the 68,466 shares held by The BZH Trust, as previously reported, this number also includes 29,623 shares previously transferred by the Reporting Person to The BZH Trust in September 2020 and 10,626 shares previously transferred by the Reporting Person to The BZH Trust in May 2022.

Read SEC document
August 26, 2022 Filed Aug 29, 2022 21:24 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 9,291 $3.41 $31,682.31
Disclosure

SEC source: 0000921895-22-002574 · form412799001_08292022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,651

F1 · price: This transaction was executed in multiple trades at prices ranging from $3.32 to $3.47, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 342,867 shares of common stock held by the Reporting Person.

Read SEC document
August 25, 2022 Filed Aug 26, 2022 20:02 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 8,244 $3.34 $27,534.96
Disclosure

SEC source: 0000921895-22-002553 · form412799001_08262022.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390,360

F3 · price: This transaction was executed in multiple trades at prices ranging from $3.23 to $3.44, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 20:02 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 17,291 $3.23 $55,849.93
Disclosure

SEC source: 0000921895-22-002553 · form412799001_08262022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,116

F1 · price: This transaction was executed in multiple trades at prices ranging from $3.17 to $3.28, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 317,332 shares of common stock held by the Reporting Person.

Read SEC document
August 23, 2022 Filed Aug 24, 2022 20:06 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 8,939 $3.23 $28,872.97
Disclosure

SEC source: 0000921895-22-002529 · form412799001_08242022.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,825

F3 · price: This transaction was executed in multiple trades at prices ranging from $3.195 to $3.26, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above.

Read SEC document
August 22, 2022 Filed Aug 24, 2022 20:06 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 4,918 $3.16 $15,540.88
Disclosure

SEC source: 0000921895-22-002529 · form412799001_08242022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,886

F1 · price: This transaction was executed in multiple trades at prices ranging from $3.13 to $3.22, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 303,475 shares of common stock held by the Reporting Person.

Read SEC document
August 19, 2022 Filed Aug 22, 2022 20:08 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 9,608 $3.28 $31,514.24
Disclosure

SEC source: 0000921895-22-002509 · form412799001_08222022.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,968

F3 · price: This transaction was executed in multiple trades at prices ranging from $3.24 to $3.30, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above.

Read SEC document
August 18, 2022 Filed Aug 22, 2022 20:08 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 PurchaseCommon Stock 1,151 $3.19 $3,671.69
Disclosure

SEC source: 0000921895-22-002509 · form412799001_08222022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,360

F1 · price: This transaction was executed in multiple trades at prices ranging from $3.175 to $3.20, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 292,716 shares of common stock held by the Reporting Person.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:08 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 9,357 $105.39 $986,134.23
Disclosure

SEC source: 0001197452-22-000010 · wf-form4_166076690799553.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,431

Read SEC document
July 06, 2022 Filed Jul 8, 2022 20:43 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 116 Not disclosed Not disclosed
Disclosure

SEC source: 0001197452-22-000008 · wf-form4_165731297585346.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,788

F1 · shares: Reflects securities granted by Entegris, Inc. (the "Issuer") pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), entered into by and among the Issuer, CMC Materials, Inc., ("CMC") and other parties thereto. Pursuant to the terms of the Merger Agreement, (a) the Issuer acquired CMC (the "Merger"), and (b) each share of CMC common stock was converted into the right to receive $133 per share, without interest, and 0.4506 shares of Issuer common stock. The Merger closed on July 6, 2022.

F2 · shares: Represents shares of common stock held in a managed account over which the reporting person does not have any investment control. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F1 · price: Reflects securities granted by Entegris, Inc. (the "Issuer") pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2021 (the "Merger Agreement"), entered into by and among the Issuer, CMC Materials, Inc., ("CMC") and other parties thereto. Pursuant to the terms of the Merger Agreement, (a) the Issuer acquired CMC (the "Merger"), and (b) each share of CMC common stock was converted into the right to receive $133 per share, without interest, and 0.4506 shares of Issuer common stock. The Merger closed on July 6, 2022.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:08 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 GrantCommon Stock 47,493 $0.00 $0.00
Disclosure

SEC source: 0000921895-22-001804 · form412799001loy_05262022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,209

F1 · shares: Represents an award of 47,493 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023.

F2 · balance_after: Includes (a) the award described in footnote (1) above and (b) 292,716 shares of common stock held by the Reporting Person.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 21:12 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 15,043 $130.19 $1,958,448.17
Disclosure

SEC source: 0001197452-22-000006 · wf-form4_164565071748218.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,672

F1 · shares: Shares automatically withheld upon settlement of restricted stock units to satisfy tax withholding obligations.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:07 UTC ENTEGRIS INC ENTG · Entity 3271 Tax withholdingCommon Stock 10,653 $124.48 $1,326,085.44
Disclosure

SEC source: 0001197452-22-000004 · wf-form4_164495924519840.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,715

F3 · shares: Shares automatically withheld upon settlement of performance share units to satisfy tax withholding obligations.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:07 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 24,020 $0.00 $0.00
Disclosure

SEC source: 0001197452-22-000004 · wf-form4_164495924519840.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,368

F1 · shares: Awarded in connection with the settlement of performance share units for the 2019-2021 performance cycle.

F2 · price: Awarded pursuant to the Entegris, Inc. 2010 Stock Plan in consideration of services as an employee.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:21 UTC ENTEGRIS INC ENTG · Entity 3271 GrantEmployee Stock Option (Right to Buy) · Derivative 60,392 $0.00 Strike: $128.44 $0.00
Disclosure

SEC source: 0001197452-22-000002 · wf-form4_164392328278185.xml · derivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,392

Underlying: Common Stock · 60,392 shares

Expires 2029-02-19

F2 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2023 and thereafter on February 19, 2024, February 19, 2025 and February 19, 2026.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:21 UTC ENTEGRIS INC ENTG · Entity 3271 GrantCommon Stock 27,248 $0.00 $0.00
Disclosure

SEC source: 0001197452-22-000002 · wf-form4_164392328278185.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,348

F1 · shares: These shares are restricted stock units with restrictions that lapse over a four-year period with respect to 25% of these shares per year, beginning February 19, 2023 and thereafter on February 19, 2024, February 19, 2025 and February 19, 2026.

F2 · price: Awarded pursuant to the Entegris, Inc. 2020 Stock Plan in consideration of services as an employee.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 00:51 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 GrantCommon Stock 4,489 $0.00 $0.00
Disclosure

SEC source: 0000921895-22-000034 · form412799loy_01032022.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,716

F1 · shares: Represents an award of 4,489 restricted stock units that will vest in full on the date of the Issuer's 2022 Annual Meeting of the Stockholders.

F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, and (c) 273,827 shares of common stock held by the Reporting Person.

Read SEC document
December 28, 2021 Filed Dec 29, 2021 21:22 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 GrantCommon Stock 1,401 $0.00 $0.00
Disclosure

SEC source: 0000921895-21-002902 · form412799001loy_12292021.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,227

F1 · shares: Represents an award of 1,401 restricted stock units that fully vest on December 31, 2021.

F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, (c) an award of 5,325 remaining unvested restricted stock units that fully vest on December 29, 2021, and (d) 267,101 shares of common stock held by the Reporting Person.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 20:02 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 200 $119.98 $23,995.00
Disclosure

SEC source: 0001197452-21-000017 · wf-form4_162888493321408.xml · nonDerivative · entry 5

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 0

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F6 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $119.95 to $120.00, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 20:02 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 2,540 $119.26 $302,917.86
Disclosure

SEC source: 0001197452-21-000017 · wf-form4_162888493321408.xml · nonDerivative · entry 4

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 200

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F5 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $118.795 to $119.67, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 20:02 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 1,860 $118.09 $219,645.35
Disclosure

SEC source: 0001197452-21-000017 · wf-form4_162888493321408.xml · nonDerivative · entry 3

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 2,740

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F4 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $117.655 to $118.61, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 20:02 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 1,900 $117.04 $222,368.78
Disclosure

SEC source: 0001197452-21-000017 · wf-form4_162888493321408.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 4,600

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F3 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $116.64 to $117.47, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 20:02 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 17,210 $116.04 $1,997,096.59
Disclosure

SEC source: 0001197452-21-000017 · wf-form4_162888493321408.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 6,500

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F2 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $115.53 to $116.47, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 10, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 800 $121.64 $97,309.04
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 8

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 23,710

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F9 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $121.27 to $121.81, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 10, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 10,441 $120.74 $1,260,672.44
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 7

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 24,510

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F8 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $120.25 to $121.22, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 10, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 53,759 $119.87 $6,444,166.59
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 6

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 34,951

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F7 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $119.25 to $120.24, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 300 $122.86 $36,858.18
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 5

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 88,710

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F6 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $122.52 to $123.02, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 47,225 $121.66 $5,745,209.32
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 4

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 89,010

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F5 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $121.33 to $122.10, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 17,475 $121.03 $2,115,011.48
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 3

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 136,235

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F4 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $120.33 to $121.32, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 7,074 $121.65 $860,570.49
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,100

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F3 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $121.37 to $122.00, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:06 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 2,732 $121.01 $330,604.24
Disclosure

SEC source: 0001197452-21-000015 · wf-form4_162871234333190.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,174

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F2 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $120.33 to $121.32, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:08 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 2,000 $126.10 $252,209.20
Disclosure

SEC source: 0001197452-21-000013 · wf-form4_162828049357497.xml · nonDerivative · entry 4

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 153,710

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F5 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $126.00 to $126.27, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:08 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 37,178 $125.41 $4,662,455.80
Disclosure

SEC source: 0001197452-21-000013 · wf-form4_162828049357497.xml · nonDerivative · entry 3

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 155,710

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F4 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.96, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:08 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 900 $126.12 $113,510.88
Disclosure

SEC source: 0001197452-21-000013 · wf-form4_162828049357497.xml · nonDerivative · entry 2

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,906

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F3 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $126.02 to $126.21, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 04, 2021 Filed Aug 6, 2021 20:08 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 16,100 $125.38 $2,018,590.63
Disclosure

SEC source: 0001197452-21-000013 · wf-form4_162828049357497.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,806

F1 · kind: These shares were sold pursuant to a Rule 10b-5 Trading Plan established by the Reporting Person on March 10, 2021.

F2 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.97, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 25, 2021 Filed May 27, 2021 20:17 UTC HARVARD BIOSCIENCE INC HBIO · Entity 7369 GrantCommon Stock 14,400 $0.00 $0.00
Disclosure

SEC source: 0000921895-21-001511 · form412799loy_05272021.xml · nonDerivative · entry 1

LOY BERTRAND · CIK 0001197452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,826

F1 · shares: Represents an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022.

F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 15,975 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2021, September 30, 2021 and December 31, 2021, and (c) 256,451 shares of common stock held by the Reporting Person.

Read SEC document
April 14, 2021 Filed Apr 14, 2021 23:01 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 15,153 $119.29 $1,807,540.76
Disclosure

SEC source: 0001197452-21-000010 · wf-form4_161844127417706.xml · nonDerivative · entry 12

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,906

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan established by the Reporting Person on March 4, 2021.

F13 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $119.05 to $119.825, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 14, 2021 Filed Apr 14, 2021 23:01 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 58,055 $118.51 $6,879,865.83
Disclosure

SEC source: 0001197452-21-000010 · wf-form4_161844127417706.xml · nonDerivative · entry 11

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,059

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan established by the Reporting Person on March 4, 2021.

F12 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $118.05 to $119.04, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 14, 2021 Filed Apr 14, 2021 23:01 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 26,792 $117.78 $3,155,642.14
Disclosure

SEC source: 0001197452-21-000010 · wf-form4_161844127417706.xml · nonDerivative · entry 10

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,114

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan established by the Reporting Person on March 4, 2021.

F11 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $117.05 to $118.04, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 13, 2021 Filed Apr 14, 2021 23:01 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 400 $120.52 $48,208.40
Disclosure

SEC source: 0001197452-21-000010 · wf-form4_161844127417706.xml · nonDerivative · entry 9

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,906

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan established by the Reporting Person on March 4, 2021.

F10 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $120.49 to $120.57, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 13, 2021 Filed Apr 14, 2021 23:01 UTC ENTEGRIS INC ENTG · Entity 3271 SaleCommon Stock 3,400 $119.46 $406,167.40
Disclosure

SEC source: 0001197452-21-000010 · wf-form4_161844127417706.xml · nonDerivative · entry 8

LOY BERTRAND · CIK 0001197452 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,306

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 Trading Plan established by the Reporting Person on March 4, 2021.

F9 · price: The price reported in column 4 is a weighted average price reported in reliance on a letter from the Office of Chief Counsel, Securities and Exchange Commission's Division of Corporate Finance to the Society of Corporate Governance Professionals dated June 25, 2008. These shares were sold in multiple transactions at prices ranging from $119.27 to $120.05, inclusive. The reporting person undertakes to provide Entegris, Inc., any shareholder of Entegris, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.